Zenicor Medical Systems AB (publ)
Financial advisor in connection with the rights issue
We have acted as financial advisor to Zenicor Medical Systems AB (publ) regarding a rights issue of SEK 16 million, which secures Zenicor’s working capital needs at least through 2026.
Zenicor is a medtech company focused on developing systems and care pathways for arrhythmia diagnostics and stroke prevention.
Polar Advisory congratulates Zenicor on the successful transaction and looks forward to supporting their continued growth journey.
Zenicor is a medtech company focused on developing systems and care pathways for arrhythmia diagnostics and stroke prevention.
Polar Advisory congratulates Zenicor on the successful transaction and looks forward to supporting their continued growth journey.
SEK 16m
2025 | Medtech
Other transactions
Insig AB (publ)
SEK 93m
2026 | Real Estate
Financial advisor in connection with a directed share issue of preference shares and warrants and a listing on NGM Nordic SME
Medituner AB
SEK 16m
2025 | Medtech
Financial advisor in connection with the private placement
Tribox Group AB (publ)
SEK 20 + 30m
2025 | Chemicals
Strategic and financial advisor regarding a directed share issue to finance the acquisition of a filter company
Tempest Security AB (publ)
SEK 12m
2025 | Security Services
Financial advisor in a secondary transaction and strategic advisor to Tempest Security in the appointment of new board members
Carla AB
SEK 52m
2025 | Consumer Discretionary
Financial advisor in connection with the private placement
Insig AB
SEK 50m
2025 | Real Estate
Financial advisor regarding capital raising transactions
Dentme International AB (publ)
SEK 150m
2025 | Healthcare
Selling agent in connection with the private placement
Netel Holding AB (publ)
SEK 192m
2025 | Industrials
Sole manager and bookrunner in connection with IK Partners sale of its entire holding in Netel Holding AB (publ)
